---
layout: default
title: Vinorelbine
description: "Vinorelbine çš„è€è—¥æ–°ç”¨æ½›åŠ›åˆ†æã€‚ä¸­ç­‰è­‰æ“šç­‰ç´š L3ï¼ŒåŒ…å« 10 å€‹é æ¸¬é©æ‡‰ç—‡ã€‚æŸ¥çœ‹ AI é æ¸¬èˆ‡è‡¨åºŠè­‰æ“šå®Œæ•´å ±å‘Šã€‚"
parent: ä¸­è­‰æ“šç­‰ç´š (L3-L4)
nav_order: 191
evidence_level: L1
indication_count: 10
---

# Vinorelbine

<p style="font-size: 1.25rem; color: #666; margin-bottom: 1.5rem;">
è­‰æ“šç­‰ç´š: <strong>L3</strong> | é æ¸¬é©æ‡‰ç—‡: <strong>10</strong> å€‹
</p>

---

<div id="pharmacist">

## è—¥å¸«è©•ä¼°å ±å‘Š

</div>

# Vinorelbineï¼šå¾éå°ç´°èƒè‚ºç™Œåˆ° Ewing è‚‰ç˜¤

## ä¸€å¥è©±ç¸½çµ

<p class="key-answer" data-question="Vinorelbine å¯ä»¥ç”¨æ–¼æ²»ç™‚ä»€éº¼æ–°é©æ‡‰ç—‡ï¼Ÿ">
Vinorelbine åŸæœ¬ç”¨æ–¼æ²»ç™‚éå°ç´°èƒè‚ºç™Œå’Œè½‰ç§»æ€§ä¹³ç™Œã€‚
TxGNN æ¨¡å‹é æ¸¬å®ƒå¯èƒ½å° **Ewing è‚‰ç˜¤ (Ewing sarcoma)** æœ‰æ•ˆï¼Œ
ç›®å‰æœ‰ **4 å€‹è‡¨åºŠè©¦é©—**æ”¯æŒé€™å€‹æ–¹å‘ã€‚
</p>

## å¿«é€Ÿç¸½è¦½

| é …ç›® | å…§å®¹ |
|------|------|
| åŸé©æ‡‰ç—‡ | éå°ç´°èƒè‚ºç™Œã€è½‰ç§»æ€§ä¹³ç™Œ |
| é æ¸¬æ–°é©æ‡‰ç—‡ | Ewing sarcomaã€fibromatosis, gingivalã€fibroma of lungã€lung germ cell tumorã€pulmonary sulcus neoplasmã€hamartoma of lungã€small cell lung carcinomaã€lung cancerã€lung benign neoplasmã€lung hilum carcinoma |
| TxGNN é æ¸¬åˆ†æ•¸ | 99.999% |
| è­‰æ“šç­‰ç´š | L3 |
| å°ç£ä¸Šå¸‚ | å·²ä¸Šå¸‚ |
| è¨±å¯è­‰æ•¸ | 19 å¼µ |
| å»ºè­°æ±ºç­– | Proceed with Guardrails |





## é æ¸¬é©æ‡‰ç—‡è©³ç´°åˆ†æ

<details class="indication-section" open>
<summary>
<span class="indication-name">1. Ewing sarcoma</span>
<span class="evidence-badge evidence-L2">L2</span>
<span class="prediction-score">100.00%</span> <span class="primary-badge">ä¸»è¦åˆ†æ</span>
</summary>
<div class="indication-content">

<h3>ç‚ºä»€éº¼é€™å€‹é æ¸¬åˆç†ï¼Ÿ</h3>

<p><p class="key-answer" data-question="é€™å€‹è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰æ˜¯ä»€éº¼ï¼Ÿ"></p>
<p>Vinorelbine æ˜¯åŠåˆæˆçš„é•·æ˜¥èŠ±ç”Ÿç‰©é¹¼ï¼ˆVinca alkaloidï¼‰ï¼Œé€éé˜»æ–·å¾®ç®¡è›‹ç™½èšåˆæŠ‘åˆ¶æœ‰çµ²åˆ†è£‚ã€‚Ewing è‚‰ç˜¤æ˜¯ä¸€ç¨®é«˜åº¦å¢æ®–çš„æƒ¡æ€§è…«ç˜¤ï¼Œå°å¾®ç®¡æŠ‘åˆ¶åŠ‘å…·æœ‰æ•æ„Ÿæ€§ã€‚Vinorelbine åœ¨å¤šé …å…’ç«¥é›£æ²»æ€§è…«ç˜¤çš„è‡¨åºŠè©¦é©—ä¸­å±•ç¾æ´»æ€§ï¼ŒåŒ…æ‹¬ Ewing è‚‰ç˜¤ã€‚</p>
<p></p></p>

<p><div class="key-takeaway"></p>
<p>æ­¤é æ¸¬åŸºæ–¼è—¥ç‰©çš„ä½œç”¨æ©Ÿè½‰ï¼Œèˆ‡ç¾æœ‰è‡¨åºŠè­‰æ“šæ–¹å‘ä¸€è‡´ã€‚</p>

<h3>è‡¨åºŠè©¦é©—</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06451302" target="_blank">NCT06451302</a></td><td>NA</td><td>ACTIVE_NOT_RECRUITING</td><td>100</td><td>A Prospective Multicenter Cohort Study of Outcome and Safety Profile of Risk Str...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00003234" target="_blank">NCT00003234</a></td><td>PHASE2</td><td>COMPLETED</td><td>50</td><td>A Phase II Study of Navelbine (Vinorelbine) In Children With Recurrent Or Refrac...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00180947" target="_blank">NCT00180947</a></td><td>PHASE2</td><td>UNKNOWN</td><td>210</td><td>Phase II Study of Vinorelbine + Cyclofosfamide Association Among Patients Reache...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT05999994" target="_blank">NCT05999994</a></td><td>PHASE2</td><td>RECRUITING</td><td>105</td><td>CAMPFIRE: Children&#x27;s and Young Adult Master Protocol for Innovative Pediatric Re...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">2. fibromatosis, gingival</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">3. fibroma of lung</span>
<span class="evidence-badge evidence-L5">L5</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<div class="no-evidence-notice">
ç›®å‰å°šç„¡é‡å°æ­¤é©æ‡‰ç—‡çš„å°ˆé–€è‡¨åºŠç ”ç©¶ã€‚æ­¤ç‚º TxGNN æ¨¡å‹é æ¸¬çµæœï¼Œéœ€é€²ä¸€æ­¥é©—è­‰ã€‚
</div>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">4. lung germ cell tumor</span>
<span class="evidence-badge evidence-L2">L2</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ3 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02489903" target="_blank">NCT02489903</a></td><td>PHASE2</td><td>COMPLETED</td><td>139</td><td>A Phase II Study of RRx-001 in Platinum Refractory/Resistant Small Cell Carcinom...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03951142" target="_blank">NCT03951142</a></td><td>PHASE2</td><td>UNKNOWN</td><td>165</td><td>Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label L...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01155258" target="_blank">NCT01155258</a></td><td>PHASE1</td><td>COMPLETED</td><td>19</td><td>Phase I Clinical Trial of Temsirolimus and Vinorelbine in Advanced Solid Tumors.</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ13 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30025492/" target="_blank">30025492</a></td><td>2018</td><td>Article</td><td>Journal of chemotherapy (Flore</td><td>Vinorelbine&#x27;s anti-tumor actions may depend on the mitotic apoptosis, autophagy ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/37458143/" target="_blank">37458143</a></td><td>2024</td><td>Article</td><td>Fundamental &amp; clinical pharmac</td><td>Dose-dependent bidirectional pharmacological effects of vinorelbine-based metron...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19699548/" target="_blank">19699548</a></td><td>2010</td><td>Article</td><td>Lung cancer (Amsterdam, Nether</td><td>Comparison of chemotherapy for unresectable pulmonary high-grade non-small cell ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28572122/" target="_blank">28572122</a></td><td>2017</td><td>Article</td><td>The European respiratory journ</td><td>Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regime...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33525370/" target="_blank">33525370</a></td><td>2021</td><td>Article</td><td>Medicina (Kaunas, Lithuania)</td><td>Outcomes of Patients with Pulmonary Large Cell Neuroendocrine Carcinoma in I-IV ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11682323/" target="_blank">11682323</a></td><td>2001</td><td>Article</td><td>Critical reviews in oncology/h</td><td>Vinflunine, the latest Vinca alkaloid in clinical development. A review of its p...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17652109/" target="_blank">17652109</a></td><td>2007</td><td>Article</td><td>Japanese journal of clinical o</td><td>Effect of platinum combined with irinotecan or paclitaxel against large cell neu...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10597209/" target="_blank">10597209</a></td><td>1999</td><td>Article</td><td>International journal of cance</td><td>Treatment of patients with cisplatin-refractory testicular germ-cell cancer. Ger...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15538626/" target="_blank">15538626</a></td><td>2005</td><td>Article</td><td>Journal of cancer research and</td><td>Complexity in the treatment of pulmonary large cell neuroendocrine carcinoma.</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9554586/" target="_blank">9554586</a></td><td>1998</td><td>Article</td><td>Cancer chemotherapy and pharma</td><td>Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10649251/" target="_blank">10649251</a></td><td>2000</td><td>Article</td><td>Cancer</td><td>A clinical trial of intravenous vinorelbine tartrate plus tamoxifen in the treat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/19443399/" target="_blank">19443399</a></td><td>2009</td><td>Article</td><td>Anticancer research</td><td>Carboplatin and vinorelbine combined with subcutaneous interleukin-2 in metastat...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/22943430/" target="_blank">22943430</a></td><td>2012</td><td>Article</td><td>Respirology (Carlton, Vic.)</td><td>Large-cell neuroendocrine carcinoma with epidermal growth factor receptor mutati...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">5. pulmonary sulcus neoplasm</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ4 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26730751/" target="_blank">26730751</a></td><td>2015</td><td>Article</td><td>Chinese clinical oncology</td><td>Combined treatment modalities in Pancoast tumor: results of a monocentric retros...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25886271/" target="_blank">25886271</a></td><td>2015</td><td>Article</td><td>BMC cancer</td><td>Ion therapy within the trimodal management of superior sulcus tumors: the INKA t...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30689794/" target="_blank">30689794</a></td><td>2019</td><td>Article</td><td>European journal of cardio-tho</td><td>Trimodality therapy for superior sulcus tumour: experience of a single instituti...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31664634/" target="_blank">31664634</a></td><td>2019</td><td>Article</td><td>Surgical case reports</td><td>Adenocarcinoma with fetal features invading the right superior sulcus treated wi...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">6. hamartoma of lung</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ1 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/15143989/" target="_blank">15143989</a></td><td>2004</td><td>Article</td><td>Tumori</td><td>Spontaneous splenic rupture after the start of lung cancer chemotherapy. A case ...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">7. small cell lung carcinoma</span>
<span class="evidence-badge evidence-L1">L1</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>è‡¨åºŠè©¦é©—ï¼ˆ50 é …ï¼‰</h3>

<table>
<thead>
<tr><th>è©¦é©—ç·¨è™Ÿ</th><th>éšæ®µ</th><th>ç‹€æ…‹</th><th>äººæ•¸</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03652857" target="_blank">NCT03652857</a></td><td>PHASE2</td><td>COMPLETED</td><td>30</td><td>the Effectiveness and Safety Study on Apatinib Combined With Vinorelbine Used fo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00004093" target="_blank">NCT00004093</a></td><td>PHASE1, PHASE2</td><td>TERMINATED</td><td>36</td><td>A Phase I-II Study of Induction Chemotherapy With Carboplatin and Gemcitabine, F...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02176369" target="_blank">NCT02176369</a></td><td>PHASE2</td><td>COMPLETED</td><td>120</td><td>Maintenance Metronomic Per OS Navelbine In Advanced NSCLC Patients After Previou...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01203735" target="_blank">NCT01203735</a></td><td>PHASE1, PHASE2</td><td>UNKNOWN</td><td>20</td><td>Valproic Acid in Combination With Concurrent Chemoradiotherapy Using Vinorelbine...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT04648033" target="_blank">NCT04648033</a></td><td>PHASE1</td><td>COMPLETED</td><td>21</td><td>A Phase I Trial of the Hypoxia Modifier Atovaquone in Combination With Radical C...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00004100" target="_blank">NCT00004100</a></td><td>PHASE3</td><td>UNKNOWN</td><td>N/A</td><td>Gemcitabine and Vinorelbine vs Standard Chemotherapy Containing Cisplatin for St...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01441752" target="_blank">NCT01441752</a></td><td>PHASE3</td><td>COMPLETED</td><td>349</td><td>State Administration of Traditional Chinese Medicine of Shanghai</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00499109" target="_blank">NCT00499109</a></td><td>PHASE3</td><td>COMPLETED</td><td>275</td><td>Randomized Phase III Multicenter Trial of RRM1 &amp; ERCC1 Directed Customized Chemo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00026156" target="_blank">NCT00026156</a></td><td>PHASE2</td><td>COMPLETED</td><td>125</td><td>Phase II Trial of Sequential Vinorelbine and Docetaxel in Advanced Non-Small Cel...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00148291" target="_blank">NCT00148291</a></td><td>PHASE3</td><td>COMPLETED</td><td>180</td><td>Phase III Study of Docetaxel Vs Vinorelbine in Elderly Patients With Advanced No...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00333294" target="_blank">NCT00333294</a></td><td>PHASE2</td><td>COMPLETED</td><td>50</td><td>A Phase II Open-Label Multicentre Study Of The Efficacy Of ZD1839 (IRESSAâ„¢) In C...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00312819" target="_blank">NCT00312819</a></td><td>PHASE2, PHASE3</td><td>COMPLETED</td><td>60</td><td>Randomized Phase 2 Trial of Treatment of Advanced Non Small Cell Lung Carcinoma ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01443078" target="_blank">NCT01443078</a></td><td>PHASE2</td><td>COMPLETED</td><td>42</td><td>Phase II Trial of Neoadjuvant Platinum-based Chemotherapy for Patients With Rese...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06853678" target="_blank">NCT06853678</a></td><td>NA</td><td>RECRUITING</td><td>30</td><td>Selinexor Combined With Nab-paclitaxel and Adebrelimab as Second-line Treatment ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00295672" target="_blank">NCT00295672</a></td><td>PHASE2</td><td>COMPLETED</td><td>60</td><td>Oral Vinorelbine and Cisplatin and Concurrent Radiotherapy After Induction Chemo...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01167530" target="_blank">NCT01167530</a></td><td>PHASE1</td><td>UNKNOWN</td><td>36</td><td>Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03823625" target="_blank">NCT03823625</a></td><td>PHASE2</td><td>UNKNOWN</td><td>112</td><td>SQUINT (Squamous Immunotherapy Nivolumab-Ipilimumab Trial): An Open-label, Rando...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00004096" target="_blank">NCT00004096</a></td><td>PHASE1, PHASE2</td><td>COMPLETED</td><td>N/A</td><td>A Phase I/II Study of Carboplatin and Navelbine for Advanced Non-Small Cell Lung...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00309998" target="_blank">NCT00309998</a></td><td>PHASE2</td><td>COMPLETED</td><td>50</td><td>Vinorelbine Plus Bevacizumab as First Line Therapy in Patients â‰¥ 70 Years of Age...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02805530" target="_blank">NCT02805530</a></td><td>NA</td><td>COMPLETED</td><td>36</td><td>Radical Treatment of Synchronous Oligometastatic Disease and Primary Tumor in Ad...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01029678" target="_blank">NCT01029678</a></td><td>PHASE2</td><td>COMPLETED</td><td>48</td><td>Phase II Study Evaluating Treatment With Oral Navelbine and Cisplatin Administer...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00042315" target="_blank">NCT00042315</a></td><td>PHASE3</td><td>TERMINATED</td><td>490</td><td>A Double-Blind, Randomized, Placebo-Controlled, Multicenter, Phase III Study of ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00008333" target="_blank">NCT00008333</a></td><td>PHASE2</td><td>COMPLETED</td><td>59</td><td>Oral Vinorelbine For The Treatment Of Metastatic Non-Small Cell Lung Cancer In P...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00165334" target="_blank">NCT00165334</a></td><td>PHASE2</td><td>COMPLETED</td><td>53</td><td>Phase II Trial of Cetuximab Plus Vinorelbine in Previously Untreated Patients &gt; ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03770299" target="_blank">NCT03770299</a></td><td>PHASE2</td><td>WITHDRAWN</td><td>0</td><td>A Phase 2 Multi-Center Randomized Trial to Assess Early Intervention With Adjuva...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00686959" target="_blank">NCT00686959</a></td><td>PHASE3</td><td>COMPLETED</td><td>598</td><td>Phase 3 Study of Pemetrexed, Cisplatin, and Radiotherapy Followed by Consolidati...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01752517" target="_blank">NCT01752517</a></td><td>N/A</td><td>UNKNOWN</td><td>60</td><td>A Phase â…¡ Single-arm Clinical Trial to Investigate the Efficacy and Safety of Vi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00432562" target="_blank">NCT00432562</a></td><td>PHASE1</td><td>COMPLETED</td><td>31</td><td>A Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion (ANX-530) in ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01454934" target="_blank">NCT01454934</a></td><td>PHASE3</td><td>COMPLETED</td><td>540</td><td>A Randomized, Open-label, Multicenter, Phase 3 Study to Compare the Efficacy and...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00298415" target="_blank">NCT00298415</a></td><td>PHASE3</td><td>COMPLETED</td><td>451</td><td>Phase III Study of Monotherapy by Gemcitabine or Vinorelbine Comparing to Double...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03456076" target="_blank">NCT03456076</a></td><td>PHASE3</td><td>ACTIVE_NOT_RECRUITING</td><td>257</td><td>A Phase III, Open-Label, Randomized Study to Evaluate the Efficacy and Safety of...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01843647" target="_blank">NCT01843647</a></td><td>PHASE2</td><td>UNKNOWN</td><td>100</td><td>Randomized, Controlled, Multicenter Study of Neoadjuvant Therapy With Icotinib i...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00003587" target="_blank">NCT00003587</a></td><td>PHASE2</td><td>COMPLETED</td><td>204</td><td>Randomized Phase II Trial of Carboplatin/Gemcitabine Followed By Paclitaxel or C...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00265694" target="_blank">NCT00265694</a></td><td>PHASE3</td><td>UNKNOWN</td><td>N/A</td><td>A Randomized Phase III Trial of Vinorelbine Versus Gemcitabine and Carboplatin f...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00002583" target="_blank">NCT00002583</a></td><td>PHASE3</td><td>COMPLETED</td><td>482</td><td>A Phase III Prospective Randomized Study of Adjuvant Chemotherapy With Vinorelbi...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00620971" target="_blank">NCT00620971</a></td><td>PHASE2</td><td>COMPLETED</td><td>77</td><td>Sequential Cisplatin/Vinorelbine/Bevacizumab Followed by Docetaxel/Gemcitabine/B...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06540950" target="_blank">NCT06540950</a></td><td>PHASE2</td><td>ACTIVE_NOT_RECRUITING</td><td>47</td><td>Study of Oral Vinorelbine Single Drug Concurrent Chemoradiotherapy and Immune-ma...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT06310915" target="_blank">NCT06310915</a></td><td>N/A</td><td>RECRUITING</td><td>30</td><td>This Study is a Pilot Study in Driver-negative Locally Advanced/Late-stage Nonsm...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00014430" target="_blank">NCT00014430</a></td><td>PHASE1</td><td>COMPLETED</td><td>13</td><td>Phase I Clinical Trial Of Vinorelbine (Navelbine) And Trastuzumab (Herceptin) In...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02579564" target="_blank">NCT02579564</a></td><td>PHASE3</td><td>UNKNOWN</td><td>134</td><td>Systemic Chemotherapy Combined With Thoracic Cavity Perfusion of Recombinant Hum...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01196078" target="_blank">NCT01196078</a></td><td>PHASE4</td><td>COMPLETED</td><td>114</td><td>A Phase II Randomized Trial of Erlotinib or Vinorelbine in Chemo-naive, Advanced...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03986463" target="_blank">NCT03986463</a></td><td>N/A</td><td>COMPLETED</td><td>40</td><td>CIrculating Tumour DNA in Lung Cancer (CITaDeL): Optimizing Sensitivity and Clin...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00083083" target="_blank">NCT00083083</a></td><td>PHASE2</td><td>UNKNOWN</td><td>250</td><td>Positron Emission Tomography Pre- and Post-treatment Assessment For Locally Adva...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00256711" target="_blank">NCT00256711</a></td><td>PHASE2</td><td>COMPLETED</td><td>192</td><td>A Randomised, Open Label, Parallel Group, Multi-Centre, Phase II Study of Progre...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT00198432" target="_blank">NCT00198432</a></td><td>PHASE2</td><td>COMPLETED</td><td>130</td><td>Randomized Phase II Study Evaluating an Induction Chemotherapy Followed by a Con...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT03117335" target="_blank">NCT03117335</a></td><td>PHASE3</td><td>COMPLETED</td><td>560</td><td>Recombinant Endostatin With Vinorelbine and Cisplatin (NP) Plus Maintenance Ther...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01848613" target="_blank">NCT01848613</a></td><td>PHASE4</td><td>COMPLETED</td><td>120</td><td>Randomized Cross-over Study of Patient Preference for Oral or Intravenous Vinore...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01850147" target="_blank">NCT01850147</a></td><td>PHASE2</td><td>UNKNOWN</td><td>50</td><td>Study of Efficacy and Safety of Sequential Low-dose Sunitinib With Chemotherapy ...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT02352948" target="_blank">NCT02352948</a></td><td>PHASE3</td><td>COMPLETED</td><td>597</td><td>A Phase III, Open Label, Randomised, Multi-centre, International Study of MEDI47...</td></tr>
<tr><td><a href="https://clinicaltrials.gov/study/NCT01683682" target="_blank">NCT01683682</a></td><td>PHASE1</td><td>COMPLETED</td><td>8</td><td>An Open Label Phase I Dose Escalation Trial of Oral BIBF 1120 in Combination Wit...</td></tr>
</tbody>
</table>

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32407216/" target="_blank">32407216</a></td><td>2020</td><td>Article</td><td>Journal of clinical oncology :</td><td>Randomized Phase III Study of Pemetrexed Plus Cisplatin Versus Vinorelbine Plus ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16945766/" target="_blank">16945766</a></td><td>2006</td><td>Article</td><td>The Lancet. Oncology</td><td>Adjuvant vinorelbine plus cisplatin versus observation in patients with complete...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31935454/" target="_blank">31935454</a></td><td>2020</td><td>Article</td><td>Pharmacological research</td><td>Clinical efficacy and safety of aidi injection combination with vinorelbine and ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36027483/" target="_blank">36027483</a></td><td>2022</td><td>Article</td><td>Journal of clinical oncology :</td><td>Updated Overall Survival and Exploratory Analysis From Randomized, Phase II EVAN...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31262897/" target="_blank">31262897</a></td><td>2019</td><td>Article</td><td>Anticancer research</td><td>Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Mul...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9535205/" target="_blank">9535205</a></td><td>1998</td><td>Article</td><td>Seminars in oncology</td><td>A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of t...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/28055291/" target="_blank">28055291</a></td><td>2017</td><td>Article</td><td>Cancer biology &amp; therapy</td><td>Metuzumab enhanced chemosensitivity and apoptosis in non-small cell lung carcino...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/36043147/" target="_blank">36043147</a></td><td>2022</td><td>Article</td><td>Contrast media &amp; molecular ima</td><td>Study on Effects of Cyclophosphamide Combined with Vinorelbine in Advanced Small...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33332223/" target="_blank">33332223</a></td><td>2023</td><td>Article</td><td>Cancer biotherapy &amp; radiopharm</td><td>Efficacy and Safety of 8 spheres Plus Cisplatin Versus Vinorelbine Plus Cisplati...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38851648/" target="_blank">38851648</a></td><td>2024</td><td>Article</td><td>Clinical &amp; translational oncol</td><td>Efficacy and safety of metronomic oral vinorelbine and its combination therapy a...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33360044/" target="_blank">33360044</a></td><td>2021</td><td>Article</td><td>Biomedicine &amp; pharmacotherapy </td><td>Synergy between vinorelbine and afatinib in the inhibition of non-small cell lun...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33496142/" target="_blank">33496142</a></td><td>2020</td><td>Article</td><td>Zhongguo Zhong yao za zhi = Zh</td><td>[Effect and mechanism of aspirin combined with vinorelbine on non-small cell lun...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33685421/" target="_blank">33685421</a></td><td>2021</td><td>Article</td><td>BMC cancer</td><td>A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33790554/" target="_blank">33790554</a></td><td>2021</td><td>Article</td><td>International journal of nanom</td><td>Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Mi...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32191330/" target="_blank">32191330</a></td><td>2020</td><td>Article</td><td>JAMA network open</td><td>Efficacy and Safety of Apatinib Plus Vinorelbine in Patients With Wild-Type Adva...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31446990/" target="_blank">31446990</a></td><td>2019</td><td>Article</td><td>Lung cancer (Amsterdam, Nether</td><td>Oral vinorelbine versus etoposide with cisplatin and chemo-radiation as treatmen...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/39630019/" target="_blank">39630019</a></td><td>2025</td><td>Article</td><td>International journal of cance</td><td>Preclinical studies on the antitumor and non-toxic effect of combining pirfenido...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31894704/" target="_blank">31894704</a></td><td>2020</td><td>Article</td><td>Future oncology (London, Engla</td><td>Open-label Phase II trial to evaluate safety and efficacy of second-line metrono...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25750330/" target="_blank">25750330</a></td><td>2015</td><td>Article</td><td>Anticancer research</td><td>Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer w...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30542768/" target="_blank">30542768</a></td><td>2019</td><td>Article</td><td>Cancer chemotherapy and pharma</td><td>Clinical outcomes of oral metronomic vinorelbine in advanced non-small cell lung...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">8. lung benign neoplasm</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ20 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16945766/" target="_blank">16945766</a></td><td>2006</td><td>Article</td><td>The Lancet. Oncology</td><td>Adjuvant vinorelbine plus cisplatin versus observation in patients with complete...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/25750330/" target="_blank">25750330</a></td><td>2015</td><td>Article</td><td>Anticancer research</td><td>Vinorelbine and cisplatin in patients with advanced non-small cell lung cancer w...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11325488/" target="_blank">11325488</a></td><td>2001</td><td>Article</td><td>Lung cancer (Amsterdam, Nether</td><td>Carboplatin and vinorelbine in untreated locally advanced and metastatic non-sma...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12454762/" target="_blank">12454762</a></td><td>2002</td><td>Article</td><td>British journal of cancer</td><td>Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced n...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32416433/" target="_blank">32416433</a></td><td>2020</td><td>Article</td><td>Lung cancer (Amsterdam, Nether</td><td>Metronomic oral vinorelbine and lung cancer therapy during the COVID 19 pandemic...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/26584409/" target="_blank">26584409</a></td><td>2016</td><td>Article</td><td>Future oncology (London, Engla</td><td>Metronomic oral vinorelbine in advanced breast cancer and non-small-cell lung ca...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/24511034/" target="_blank">24511034</a></td><td>2014</td><td>Article</td><td>Anticancer research</td><td>Split-dose cisplatin and vinorelbine as adjuvant chemotherapy for completely res...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9364543/" target="_blank">9364543</a></td><td>1997</td><td>Article</td><td>Oncology (Williston Park, N.Y.</td><td>Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cel...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/16937106/" target="_blank">16937106</a></td><td>2007</td><td>Article</td><td>Cancer chemotherapy and pharma</td><td>Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: se...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/32472208/" target="_blank">32472208</a></td><td>2020</td><td>Article</td><td>International journal of clini</td><td>The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/11809985/" target="_blank">11809985</a></td><td>2002</td><td>Article</td><td>Thorax</td><td>Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinor...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/10582139/" target="_blank">10582139</a></td><td>1999</td><td>Article</td><td>Annals of oncology : official </td><td>Vinorelbine (navelbine) in the treatment of non-small-cell lung cancer: recent d...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/38851648/" target="_blank">38851648</a></td><td>2024</td><td>Article</td><td>Clinical &amp; translational oncol</td><td>Efficacy and safety of metronomic oral vinorelbine and its combination therapy a...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12151970/" target="_blank">12151970</a></td><td>2002</td><td>Article</td><td>American journal of clinical o</td><td>Vinorelbine and paclitaxel for locoregional advanced or metastatic non-small-cel...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/14751503/" target="_blank">14751503</a></td><td>2004</td><td>Article</td><td>International journal of radia</td><td>Radiosensitization of vinorelbine and gemcitabine in NCI-H460 non-small-cell lun...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/31262897/" target="_blank">31262897</a></td><td>2019</td><td>Article</td><td>Anticancer research</td><td>Cisplatin and Vinorelbine -Mediated Electrochemotherapeutic Approach Against Mul...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/33360044/" target="_blank">33360044</a></td><td>2021</td><td>Article</td><td>Biomedicine &amp; pharmacotherapy </td><td>Synergy between vinorelbine and afatinib in the inhibition of non-small cell lun...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/17600389/" target="_blank">17600389</a></td><td>2007</td><td>Article</td><td>Drugs</td><td>Oral vinorelbine in the treatment of non-small cell lung cancer: rationale and i...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/29502152/" target="_blank">29502152</a></td><td>2018</td><td>Article</td><td>Surgery today</td><td>Adjuvant vinorelbine and cisplatin after complete resection of stage II and III ...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/9535205/" target="_blank">9535205</a></td><td>1998</td><td>Article</td><td>Seminars in oncology</td><td>A review of ifosfamide and vinorelbine in advanced non-small cell carcinoma of t...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">9. lung hilum carcinoma</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ1 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/21677493/" target="_blank">21677493</a></td><td>2011</td><td>Article</td><td>Gan to kagaku ryoho. Cancer &amp; </td><td>[A radical resection of non-small cell lung cancer invading chest wall with ipsi...</td></tr>
</tbody>
</table>

</div>
</details>

<details class="indication-section">
<summary>
<span class="indication-name">10. pulmonary blastoma</span>
<span class="evidence-badge evidence-L4">L4</span>
<span class="prediction-score">99.99%</span>
</summary>
<div class="indication-content">

<h3>ç›¸é—œæ–‡ç»ï¼ˆ2 ç¯‡ï¼‰</h3>

<table>
<thead>
<tr><th>PMID</th><th>å¹´ä»½</th><th>é¡å‹</th><th>æœŸåˆŠ</th><th>ä¸»è¦ç™¼ç¾</th></tr>
</thead>
<tbody>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/30106243/" target="_blank">30106243</a></td><td>2018</td><td>Article</td><td>Thoracic cancer</td><td>Blastomatoid pulmonary carcinosarcoma: A rare case report and review of the lite...</td></tr>
<tr><td><a href="https://pubmed.ncbi.nlm.nih.gov/12088262/" target="_blank">12088262</a></td><td>2002</td><td>Article</td><td>Tumori</td><td>Pulmonary blastoma after liver transplant: a case report.</td></tr>
</tbody>
</table>

</div>
</details>


## å°ç£ä¸Šå¸‚è³‡è¨Š

| è¨±å¯è­‰è™Ÿ | å“å | åŠ‘å‹ | æ ¸å‡†é©æ‡‰ç—‡ |
|---------|------|------|-----------|
| è¡›ç½²è—¥è¼¸å­—ç¬¬022215è™Ÿ | æº«è«¾å¹³æ³¨å°„æ¶²10å…¬çµ²/å…¬æ’® | æ³¨å°„åŠ‘ | éå°ç´°èƒè‚ºç™Œï¼Œè½‰ç§»æ€§ä¹³ç™Œ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬024268è™Ÿ | æº«è«¾å¹³30æ¯«å…‹è»Ÿè† å›Š | è»Ÿè† å›ŠåŠ‘ | éå°ç´°èƒè‚ºç™Œã€è½‰ç§»æ€§ä¹³ç™Œ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬024269è™Ÿ | æº«è«¾å¹³20æ¯«å…‹è»Ÿè† å›Š | è»Ÿè† å›ŠåŠ‘ | éå°ç´°èƒè‚ºç™Œã€è½‰ç§»æ€§ä¹³ç™Œ |
| è¡›éƒ¨è—¥è£½å­—ç¬¬060608è™Ÿ | å¨è‹¥è³“30æ¯«å…‹è»Ÿè† å›Š | è»Ÿè† å›ŠåŠ‘ | éå°ç´°èƒè‚ºç™Œã€è½‰ç§»æ€§ä¹³ç™Œ |
| è¡›ç½²è—¥è¼¸å­—ç¬¬025489è™Ÿ | ç¶­è«¾æ‹œæ³¨å°„æ¶² | æ³¨å°„åŠ‘ | éå°ç´°èƒè‚ºç™Œã€è½‰ç§»æ€§ä¹³ç™Œ |

## ç´°èƒæ¯’æ€§

| é …ç›® | å…§å®¹ |
|------|------|
| ç´°èƒæ¯’æ€§åˆ†é¡ | å‚³çµ±ç´°èƒæ¯’æ€§è—¥ç‰©ï¼ˆVinca alkaloidï¼‰ |
| éª¨é«“æŠ‘åˆ¶é¢¨éšª | é«˜åº¦ï¼ˆå—œä¸­æ€§ç™½è¡€çƒæ¸›å°‘ç‚ºåŠ‘é‡é™åˆ¶æ¯’æ€§ï¼‰ |
| è‡´åæ€§åˆ†ç´š | ä½åº¦ |
| ç›£æ¸¬é …ç›® | CBCï¼ˆå«åˆ†é¡ï¼‰ã€è‚åŠŸèƒ½ã€ç¥ç¶“æ¯’æ€§è©•ä¼° |
| è™•ç½®é˜²è­· | éœ€ä¾ç´°èƒæ¯’æ€§è—¥ç‰©è™•ç½®è¦ç¯„æ“ä½œï¼›éœè„ˆæ³¨å°„éœ€æ³¨æ„å¤–æ»²é¢¨éšª |

## å®‰å…¨æ€§è€ƒé‡

### é‡å¤§è—¥ç‰©äº¤äº’ä½œç”¨ï¼ˆMajorï¼‰

| äº¤äº’ä½œç”¨è—¥ç‰© | æ©Ÿè½‰èªªæ˜ |
|-------------|---------|
| Clarithromycin | CYP3A4 æŠ‘åˆ¶åŠ‘ï¼Œå¢åŠ  vinorelbine è¡€ä¸­æ¿ƒåº¦å’Œæ¯’æ€§ |

### ä¸­åº¦è—¥ç‰©äº¤äº’ä½œç”¨ï¼ˆModerateï¼‰

| äº¤äº’ä½œç”¨è—¥ç‰© | æ©Ÿè½‰èªªæ˜ |
|-------------|---------|
| Aprepitant | CYP3A4 æŠ‘åˆ¶ |
| Dexamethasone | å¯èƒ½å½±éŸ¿ä»£è¬ |
| Simvastatin | CYP3A4 ç«¶çˆ­ |
| Rosuvastatin | è—¥ç‰©è½‰é‹é«”äº¤äº’ä½œç”¨ |

### è—¥ç‰©-é£Ÿç‰©äº¤äº’ä½œç”¨ (DFI)

**è‘¡è„æŸš** ğŸŸ¡ Moderate
- å½±éŸ¿ï¼šCYP3A4 ä»£è¬è—¥ç‰©ï¼Œè‘¡è„æŸšå¯èƒ½å½±éŸ¿ä»£è¬
- å»ºè­°ï¼šåŒ–ç™‚æœŸé–“é¿å…è‘¡è„æŸš


### è—¥ç‰©-ç–¾ç—…æ³¨æ„äº‹é … (DDSI)

<div class="ddsi-source">è³‡æ–™ä¾†æºï¼š<a href="https://ddinter2.scbdd.com/" target="_blank">DDInter 2.0</a>ï¼ˆåŸæ–‡å…§å®¹è«‹åƒé–±è©²ç¶²ç«™ï¼‰</div>

**Gastrointestinal Diseases** ğŸŸ¡ Moderate
- æ‡‰è¬¹æ…ä½¿ç”¨æœ¬è—¥ç‰©ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚å¯èƒ½æœ‰è‡´å‘½é¢¨éšªã€‚

**Neuromuscular Diseases** ğŸŸ¡ Moderate
- éœ€å®šæœŸç›£æ¸¬ã€‚å¯èƒ½æœ‰åš´é‡ä¸è‰¯åæ‡‰ã€‚å‡ºç¾ç—‡ç‹€æ™‚æ‡‰è€ƒæ…®åœè—¥ã€‚

**Respiratory Insufficiency** ğŸŸ¢ Minor
- å¯èƒ½å±åŠç”Ÿå‘½ã€‚

**è‚è‡Ÿç–¾ç—…** ğŸŸ¢ Minor
- æ³¨æ„äº‹é …ï¼šVinorelbine is extensively metabolized by the liver...

**Infections** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šéª¨é«“æŠ‘åˆ¶ã€æ„ŸæŸ“ã€è¡€æ “ã€è²§è¡€ã€‚

**Bone Marrow Failure Disorders** ğŸŸ¢ Minor
- æœ¬è—¥ç‰©åœ¨æ­¤æƒ…æ³ä¸‹ç¦ç”¨ã€‚éœ€å®šæœŸç›£æ¸¬ã€‚é¢¨éšªåŒ…æ‹¬ï¼šéª¨é«“æŠ‘åˆ¶ã€å‡ºè¡€ã€æ„ŸæŸ“ã€‚

## çµè«–èˆ‡ä¸‹ä¸€æ­¥

**æ±ºç­–ï¼šProceed with Guardrails**

**ç†ç”±ï¼š**
Vinorelbine åœ¨å¤šé …å…’ç«¥è…«ç˜¤è‡¨åºŠè©¦é©—ä¸­é¡¯ç¤ºå° Ewing è‚‰ç˜¤å…·æœ‰æ½›åœ¨ç™‚æ•ˆï¼Œä¸”ä½œç”¨æ©Ÿè½‰ï¼ˆå¾®ç®¡æŠ‘åˆ¶ï¼‰å°é«˜å¢æ®–æ€§è…«ç˜¤å…·æœ‰åˆç†çš„ç”Ÿç‰©å­¸åŸºç¤ã€‚

**è‹¥è¦æ¨é€²éœ€è¦ï¼š**
- æ”¶é›†å°ˆé–€é‡å° Ewing è‚‰ç˜¤çš„ç™‚æ•ˆæ•¸æ“š
- ç¢ºå®šé©ç•¶çš„å…’ç§‘åŠ‘é‡å’Œçµ¦è—¥æ–¹æ¡ˆ
- èˆ‡ç¾æœ‰ Ewing è‚‰ç˜¤æ¨™æº–æ²»ç™‚æ–¹æ¡ˆçš„æ¯”è¼ƒè©•ä¼°
- éª¨é«“æŠ‘åˆ¶å’Œç¥ç¶“æ¯’æ€§çš„å¯†åˆ‡ç›£æ¸¬è¨ˆç•«

---

## ç›¸é—œè—¥ç‰©å ±å‘Š

- [Propantheline]({{ "/drugs/propantheline/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Interferon Beta-1B]({{ "/drugs/interferon_beta-1b/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Dorzolamide]({{ "/drugs/dorzolamide/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Prednisolone]({{ "/drugs/prednisolone/" | relative_url }}) - è­‰æ“šç­‰ç´š L3
- [Acitretin]({{ "/drugs/acitretin/" | relative_url }}) - è­‰æ“šç­‰ç´š L3

---

{% include ai-analysis.html %}

{% include social-share.html %}

## å¼•ç”¨æœ¬å ±å‘Š

å¦‚éœ€å¼•ç”¨æœ¬å ±å‘Šï¼Œè«‹ä½¿ç”¨ä»¥ä¸‹æ ¼å¼ï¼š

**APA æ ¼å¼ï¼š**
```
TwTxGNN. (2026). Vinorelbineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š. https://twtxgnn.yao.care/drugs/vinorelbine/
```

**BibTeX æ ¼å¼ï¼š**
```bibtex
@misc{twtxgnn_vinorelbine,
  title = {Vinorelbineè€è—¥æ–°ç”¨é©—è­‰å ±å‘Š},
  author = {TwTxGNN Team},
  year = {2026},
  url = {https://twtxgnn.yao.care/drugs/vinorelbine/}
}
```

---

<div class="disclaimer">
<strong>å…è²¬è²æ˜</strong><br>
æœ¬å ±å‘Šåƒ…ä¾›å­¸è¡“ç ”ç©¶åƒè€ƒï¼Œ<strong>ä¸æ§‹æˆé†«ç™‚å»ºè­°</strong>ã€‚è—¥ç‰©ä½¿ç”¨è«‹éµå¾ªé†«å¸«æŒ‡ç¤ºï¼Œåˆ‡å‹¿è‡ªè¡Œèª¿æ•´ç”¨è—¥ã€‚ä»»ä½•è€è—¥æ–°ç”¨æ±ºç­–éœ€ç¶“éå®Œæ•´çš„è‡¨åºŠé©—è­‰èˆ‡æ³•è¦å¯©æŸ¥ã€‚
<br><br>
<small>æœ€å¾Œå¯©æ ¸ï¼š2026-02-20 | å¯©æ ¸è€…ï¼šTwTxGNN Research Team</small>
</div>

{% include giscus.html %}
